Loading...
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C virus (HCV) infects 130–170 million people worldwide. Recently, direct-acting antivirals have been shown to eradicate HCV infection in 90–95 % of non-cirrhotic patients depending on genotype, treatment experience, and regimen used. Similar rates are achieved among compensated cirrhotics,...
Na minha lista:
| Udgivet i: | Trop Dis Travel Med Vaccines |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5530934/ https://ncbi.nlm.nih.gov/pubmed/28883965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40794-016-0038-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|